IMOZX
Price
$25.58
Change
+$0.09 (+0.35%)
Updated
Jun 2 closing price
Net Assets
590.18M
PMBJX
Price
$36.06
Change
-$0.20 (-0.55%)
Updated
Jun 2 closing price
Net Assets
24.56B
Interact to see
Advertisement

IMOZX vs PMBJX

Header iconIMOZX vs PMBJX Comparison
Open Charts IMOZX vs PMBJXBanner chart's image
IMOZX vs PMBJX Comparison Chart in %
View a ticker or compare two or three
VS
IMOZX vs. PMBJX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMOZX is a Buy and PMBJX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMBJX has more cash in the bank: 24.6B vs. IMOZX (590M). IMOZX (0.00) and PMBJX (0.00) have matching dividends . IMOZX was incepted earlier than PMBJX: IMOZX (13 years) vs PMBJX (25 years). IMOZX (0.87) is less costly to investors than PMBJX (0.76). IMOZX is a more actively managed with annual turnover of: 87.00 vs. PMBJX (13.70). PMBJX has a lower initial minimum investment than IMOZX: PMBJX (1000) vs IMOZX (1000000). IMOZX annual gain was more profitable for investors over the last year : -3.85 vs. PMBJX (-13.38). PMBJX return over 5 years is better than : -1.52 vs. IMOZX (-13.65).
IMOZXPMBJXIMOZX / PMBJX
Total Expense Ratio0.830.76109%
Annual Report Gross Expense Ratio0.870.76114%
Fund Existence13 years25 years-
Gain YTD7.735-6.906-112%
Front LoadN/AN/A-
Min. Initial Investment10000001000100,000%
Min. Initial Investment IRAN/AN/A-
Net Assets590M24.6B2%
Annual Yield % from dividends0.000.00-
Returns for 1 year-3.85-13.3829%
Returns for 3 years15.7115.44102%
Returns for 5 years-13.65-1.52901%
Returns for 10 years5.4276.507%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
USAR30.701.27
+4.32%
USA Rare Earth Inc
ATNM1.220.04
+3.39%
Actinium Pharmaceuticals
HD311.520.83
+0.27%
Home Depot
HLLY2.62-0.02
-0.76%
Holley
AMLX13.29-0.78
-5.54%
Amylyx Pharmaceuticals